Ben Z. Stanger - Publications

Affiliations: 
Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Molecular Biology, Cell Biology, Human Development

161 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Markosyan N, Kim IK, Arora C, Quinones-Ware L, Joshi N, Cheng NC, Schechter EY, Tobias JW, Hochberg JE, Corse E, Liu K, Rodriguez DiBlasi V, Chan LC, Smyth EM, Fitzgerald GA, ... Stanger BZ, et al. Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing anti-tumor immunity. Jci Insight. PMID 39298269 DOI: 10.1172/jci.insight.178644  0.347
2024 Than MT, O'Hara M, Stanger BZ, Reiss KA. KRAS-driven Tumorigenesis and KRAS-driven Therapy in Pancreatic Adenocarcinoma. Molecular Cancer Therapeutics. PMID 39118358 DOI: 10.1158/1535-7163.MCT-23-0519  0.335
2024 Assouline B, Kahn R, Hodali L, Condiotti R, Engel Y, Elyada E, Mordechai-Heyn T, Pitarresi JR, Atias D, Steinberg E, Bidany-Mizrahi T, Forkosh E, Katz LH, Benny O, Golan T, ... ... Stanger BZ, et al. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8 T cell activation and limit responsiveness to immunotherapy in mice. Nature Communications. 15: 6162. PMID 39039076 DOI: 10.1038/s41467-024-50441-7  0.319
2024 Hollander EE, Flock RE, McDevitt JC, Vostrejs WP, Campbell SL, Orlen MI, Kemp SB, Kahn BM, Wellen KE, Kim IK, Stanger BZ. N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance. Jci Insight. 9. PMID 38912584 DOI: 10.1172/jci.insight.178804  0.346
2024 Sussman J, Kim NY, Kemp SB, Traum D, Katsuda T, Kahn BM, Xu J, Kim IK, Eskandarian C, Delman D, Beatty GL, Kaestner KH, Simpson AL, Stanger BZ. Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer. Cancer Research. PMID 38695869 DOI: 10.1158/0008-5472.CAN-23-2352  0.305
2024 Brown BA, Myers PJ, Adair SJ, Pitarresi JR, Sah-Teli SK, Campbell LA, Hart WS, Barbeau MC, Leong K, Seyler N, Kane W, Lee KE, Stelow E, Jones M, Simon MC, ... ... Stanger BZ, et al. A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreatic cancer. Cancer Research. PMID 38471099 DOI: 10.1158/0008-5472.CAN-22-2945  0.31
2024 Katsuda T, Sussman JH, Ito K, Katznelson A, Yuan S, Takenaka N, Li J, Merrell AJ, Cure H, Li Q, Rasool RU, Asangani IA, Zaret KS, Stanger BZ. Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity. Nature Communications. 15: 1761. PMID 38409161 DOI: 10.1038/s41467-024-45939-z  0.3
2024 Kim IK, Diamond MS, Yuan S, Kemp SB, Kahn BM, Li Q, Lin JH, Li J, Norgard RJ, Thomas SK, Merolle M, Katsuda T, Tobias JW, Baslan T, Politi K, ... ... Stanger BZ, et al. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma. Nature Communications. 15: 1532. PMID 38378697 DOI: 10.1038/s41467-024-46048-7  0.307
2023 Pitarresi JR, Stanger BZ. Cellular Origins and Lineage Plasticity in Cancer. Cold Spring Harbor Perspectives in Medicine. PMID 37604590 DOI: 10.1101/cshperspect.a041389  0.328
2023 Sussman JH, Stanger BZ. Digging deeper into the early steps of cancer progression. Trends in Cancer. PMID 37495432 DOI: 10.1016/j.trecan.2023.07.003  0.314
2023 Kim IK, Diamond M, Yuan S, Kemp S, Li Q, Lin J, Li J, Norgard R, Thomas S, Merolle M, Katsuda T, Tobias J, Politi K, Vonderheide R, Stanger B. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy. Research Square. PMID 37398248 DOI: 10.21203/rs.3.rs-2960521/v1  0.32
2023 Bianchi A, De Castro Silva I, Deshpande NU, Singh S, Mehra S, Garrido VT, Guo X, Nivelo LA, Kolonias DS, Saigh SJ, Wieder E, Rafie CI, Dosch AR, Zhou Z, Umland O, ... ... Stanger BZ, et al. Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discovery. PMID 36946782 DOI: 10.1158/2159-8290.CD-22-1046  0.343
2023 Katsuda T, Sussman J, Ito K, Katznelson A, Yuan S, Li J, Merrell AJ, Takenaka N, Cure H, Li Q, Rasool RU, Asangani IA, Zaret KS, Stanger BZ. Physiological reprogramming mediated by Sox4 pioneer factor activity. Biorxiv : the Preprint Server For Biology. PMID 36824858 DOI: 10.1101/2023.02.14.528556  0.302
2022 Halbrook CJ, Thurston G, Boyer S, Anaraki C, Jiménez JA, McCarthy A, Steele NG, Kerk SA, Hong HS, Lin L, Law FV, Felton C, Scipioni L, Sajjakulnukit P, Andren A, ... ... Stanger BZ, et al. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nature Cancer. 3: 1386-1403. PMID 36411320 DOI: 10.1038/s43018-022-00463-1  0.305
2022 McBrearty N, Cho C, Chen J, Zahedi F, Peck AR, Radaelli E, Assenmacher CA, Pavlak C, Devine A, Yu P, Lu Z, Zhang H, Li J, Pitarresi JR, Astsaturov I, ... ... Stanger BZ, et al. Tumor suppressive and immune-stimulating roles of cholesterol 25-hydroxylase in pancreatic cancer cells. Molecular Cancer Research : McR. PMID 36378658 DOI: 10.1158/1541-7786.MCR-22-0602  0.332
2022 Zhang Y, Xu Y, Lu W, Li J, Yu S, Brown EJ, Stanger BZ, Rabinowitz JD, Yang X. G6PD-mediated increase in de novo NADP biosynthesis promotes antioxidant defense and tumor metastasis. Science Advances. 8: eabo0404. PMID 35857842 DOI: 10.1126/sciadv.abo0404  0.332
2022 Sela Y, Li J, Maheswaran S, Norgard RJ, Yuan S, Hubbi ME, Doepner M, Xu JP, Ho ES, Mesaros C, Sheehan C, Croley G, Muir A, Blair IA, Shalem O, ... ... Stanger BZ, et al. Bcl-xL enforces a slow-cycling state necessary for survival in the nutrient-deprived microenvironment of pancreatic cancer. Cancer Research. PMID 35315913 DOI: 10.1158/0008-5472.CAN-22-0431  0.302
2021 Maddipati R, Norgard RJ, Baslan T, Rathi KS, Zhang A, Saeid A, Higashihara T, Wu F, Kumar A, Annamalai V, Bhattacharya S, Raman P, Adkisson CA, Pitarresi JR, Wengyn MD, ... ... Stanger BZ, et al. MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinoma. Cancer Discovery. PMID 34551968 DOI: 10.1158/2159-8290.CD-20-1826  0.773
2021 Norgard RJ, Pitarresi JR, Maddipati R, Aiello-Couzo NM, Balli D, Li J, Yamazoe T, Wengyn MD, Millstein ID, Folkert IW, Rosario-Berrios DN, Kim IK, Bassett JB, Payne R, Berry CT, ... ... Stanger BZ, et al. Calcium signaling induces a partial EMT. Embo Reports. e51872. PMID 34324787 DOI: 10.15252/embr.202051872  0.767
2021 Simeonov KP, Byrns CN, Clark ML, Norgard RJ, Martin B, Stanger BZ, Shendure J, McKenna A, Lengner CJ. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell. PMID 34115987 DOI: 10.1016/j.ccell.2021.05.005  0.308
2021 Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin D, Wirsik NM, Mehal A, Arpaia N, Seki E, Mack M, ... ... Stanger BZ, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. The Journal of Clinical Investigation. PMID 33905375 DOI: 10.1172/JCI146987  0.308
2021 Pitarresi JR, Norgard RJ, Chiarella AM, Suzuki K, Bakir B, Sahu V, Li J, Zhao J, Marchand B, Wengyn MD, Hsieh A, Kim IK, Zhang A, Sellin K, Lee V, ... ... Stanger BZ, et al. PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability. Cancer Discovery. PMID 33589425 DOI: 10.1158/2159-8290.CD-20-1098  0.338
2021 Norgard RJ, Stanger BZ. Isolation and Identification of EMT Subtypes. Methods in Molecular Biology (Clifton, N.J.). 2179: 315-326. PMID 32939730 DOI: 10.1007/978-1-0716-0779-4_24  0.471
2020 Li J, Yuan S, Norgard RJ, Yan F, Sun YH, Kim IK, Merrell AJ, Sela Y, Jiang Y, Bhanu NV, Garcia BA, Vonderheide RH, Blanco A, Stanger BZ. Epigenetic and transcriptional control of the epidermal growth factor receptor (EGFR) regulates the tumor immune microenvironment in pancreatic cancer. Cancer Discovery. PMID 33158848 DOI: 10.1158/2159-8290.CD-20-0519  0.301
2020 Li J, Stanger BZ. Cell Cycle Regulation Meets Tumor Immunosuppression. Trends in Immunology. PMID 32800703 DOI: 10.1016/J.It.2020.07.010  0.423
2020 Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, ... ... Stanger BZ, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. PMID 32795414 DOI: 10.1016/J.Cell.2020.07.009  0.325
2020 Li J, Stanger BZ. How Tumor Cell Dedifferentiation Drives Immune Evasion And Resistance to Immunotherapy. Cancer Research. PMID 32554552 DOI: 10.1158/0008-5472.Can-20-1420  0.373
2020 Natale CA, Li J, Pitarresi JR, Norgard RJ, Dentchev T, Capell BC, Seykora JT, Stanger BZ, Ridky TW. Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma. Cellular and Molecular Gastroenterology and Hepatology. PMID 32376419 DOI: 10.1016/J.Jcmgh.2020.04.016  0.311
2020 Chandrakesan P, Panneerselvam J, May R, Weygant N, Qu D, Berry WR, Pitts K, Stanger BZ, Rao CV, Bronze MS, Houchen CW. DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization. Molecular Cancer Therapeutics. PMID 32371580 DOI: 10.1158/1535-7163.Mct-19-0776  0.361
2020 Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, García de Herreros A, ... ... Stanger B, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology. PMID 32300252 DOI: 10.1038/S41580-020-0237-9  0.328
2020 Ruscetti M, Morris JP, Mezzadra R, Russell J, Leibold J, Romesser PB, Simon J, Kulick A, Ho YJ, Fennell M, Li J, Norgard RJ, Wilkinson JE, Alonso-Curbelo D, Sridharan R, ... ... Stanger BZ, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. PMID 32234521 DOI: 10.1016/J.Cell.2020.03.008  0.422
2020 Yuan S, Natesan R, Sanchez-Rivera FJ, Li J, Bhanu NV, Yamazoe T, Lin JH, Merrell AJ, Sela Y, Thomas SK, Jiang Y, Plesset JB, Miller EM, Shi J, Garcia BA, ... ... Stanger BZ, et al. Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression. Cancer Discovery. PMID 32188706 DOI: 10.1158/2159-8290.Cd-19-1299  0.405
2020 Cardenas-Diaz FL, Leavens KF, Kishore S, Osorio-Quintero C, Chen YJ, Stanger BZ, Wang P, French D, Gadue P. A dual reporter EndoC-βH1 human β-cell line for efficient quantification of calcium flux and insulin secretion. Endocrinology. PMID 31960055 DOI: 10.1210/Endocr/Bqaa005  0.336
2020 Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin J, Sun YH, Liudahl SM, Tobias JW, Lowe S, Coussens LM, Wherry JE, Vonderheide RH, ... Stanger BZ, et al. Abstract PR11: Tumor cell-intrinsic factors underlie the heterogeneity of immune infiltration and response to immunotherapy in pancreatic cancer Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-Pr11  0.436
2019 Li J, Yuan S, Norgard RJ, Yan F, Yamazoe T, Blanco A, Stanger BZ. Tumor cell-intrinsic USP22 suppresses antitumor immunity in pancreatic cancer. Cancer Immunology Research. PMID 31871120 DOI: 10.1158/2326-6066.Cir-19-0661  0.461
2019 Nguyen DT, Lee E, Alimperti S, Norgard RJ, Wong A, Lee JJ, Eyckmans J, Stanger BZ, Chen CS. A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. Science Advances. 5: eaav6789. PMID 31489365 DOI: 10.1126/Sciadv.Aav6789  0.387
2019 Mills JC, Stanger BZ, Sander M. Nomenclature for cellular plasticity: are the terms as plastic as the cells themselves? The Embo Journal. e103148. PMID 31475380 DOI: 10.15252/Embj.2019103148  0.355
2019 Qu D, Weygant N, Yao J, Chandrakesan P, Berry WL, May R, Pitts K, Husain S, Lightfoot S, Li M, Wang TC, An G, Clendenin C, Stanger BZ, Houchen CW. Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer. Journal of Oncology. 2019: 6402925. PMID 31467540 DOI: 10.1155/2019/6402925  0.413
2019 Braitsch CM, Azizoglu DB, Htike Y, Barlow HR, Schnell U, Chaney CP, Carroll TJ, Stanger BZ, Cleaver O. LATS1/2 suppress NFκB and aberrant EMT initiation to permit pancreatic progenitor differentiation. Plos Biology. 17: e3000382. PMID 31323030 DOI: 10.1371/Journal.Pbio.3000382  0.474
2019 Markosyan N, Li J, Sun YH, Richman LP, Lin JH, Yan F, Quinones L, Sela Y, Yamazoe T, Gordon N, Tobias JW, Byrne KT, Rech AJ, FitzGerald GA, Stanger BZ, et al. Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2). The Journal of Clinical Investigation. 130. PMID 31162144 DOI: 10.1172/Jci127755  0.424
2019 McDonald PC, Chafe SC, Brown WS, Saberi S, Swayampakula M, Venkateswaran G, Nemirovsky O, Gillespie JA, Karasinska JM, Kalloger SE, Supuran CT, Schaeffer DF, Bashashati A, Shah SP, Topham JT, ... ... Stanger BZ, et al. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. Gastroenterology. PMID 31078621 DOI: 10.1053/J.Gastro.2019.05.004  0.349
2019 Yuan S, Norgard RJ, Stanger BZ. Cellular Plasticity in Cancer. Cancer Discovery. PMID 30992279 DOI: 10.1158/2159-8290.Cd-19-0015  0.429
2019 Li J, Stanger BZ. The tumor as organizer model. Science (New York, N.Y.). 363: 1038-1039. PMID 30846584 DOI: 10.1126/Science.Aau9861  0.309
2019 Carrer A, Trefely S, Zhao S, Campbell S, Norgard RJ, Schultz KC, Sidoli S, Parris JLD, Affronti HC, Sivanand S, Egolf S, Sela Y, Trizzino M, Gardini A, Garcia BA, ... ... Stanger BZ, et al. Acetyl-CoA metabolism supports multi-step pancreatic tumorigenesis. Cancer Discovery. PMID 30626590 DOI: 10.1158/2159-8290.Cd-18-0567  0.302
2019 Byrne KT, Li J, Vonderheide RH, Stanger B. Abstract A054: Tumor cell intrinsic factors dictate immune cell infiltration and response to immunotherapy Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A054  0.4
2019 Ruscetti M, Morris JP, Mezzadra R, Russell J, Leibold J, Romesser PB, Simon J, Kulick A, Ho Y, Fennell M, Li J, Norgard RJ, Wilkinson JE, Alonso-Curbelo D, Sridharan R, ... ... Stanger BZ, et al. Abstract PR01: Senescence induction triggers vascular remodeling and new vulnerabilities to chemo- and immunotherapy in pancreas cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-Pr01  0.407
2019 Sela Y, Li J, Doepner M, Maheswaran S, Mesaros C, Blair I, Shalem O, Stanger B. Abstract C50: Dissecting vulnerabilities of pancreatic tumors’ silent fraction unravels secrets of an alternative cell state Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C50  0.467
2019 Clendenin C, Sor R, McMenamin D, Stanger BZ, Beatty G, Vonderheide RH. Abstract C13: A “mouse hospital” for preclinical testing of diagnostic and treatment modalities in pancreatic ductal adenocarcinoma (PDA) Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C13  0.406
2019 Pitarresi JR, Norgard RJ, Stanger BZ, Rustgi AK. Abstract B43: p120 catenin loss drives pancreatic cancer EMT and metastasis through activation of PTHrP-mediated calcium signaling Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B43  0.461
2019 Norgard RJ, Maddipati R, Aiello NM, Balli D, Pitarresi JR, Rosario-Berrios DN, Li J, Yuan S, Yamazoe T, Sela Y, Merrell AJ, Wengyn MD, Sun K, Rustgi AK, Stanger BZ. Abstract B38: Calcium signaling induces a partial EMT in pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B38  0.483
2019 Markosyan N, Li J, Sun Y, Richman L, Lin J, Yan F, Quinones L, Sela Y, Yamazoe T, Gordon N, Tobias J, Byrne K, Rech A, FitzGerald G, Stanger B, et al. Abstract B33: Tumor cell-intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2) in pancreatic adenocarcinoma Immunotherapy. 79. DOI: 10.1158/1538-7445.Panca19-B33  0.442
2019 Natale C, Li J, Dentchev T, Capell B, Seykora J, Stanger B, Ridky T. Abstract B21: Pharmacologic activation of G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B21  0.392
2019 Yuan S, Natesan R, Sanchez-Rivera FJ, Li J, Bhanu NV, Yamazoe T, Lin JH, Merrell AJ, Thomas SK, Shi J, Garcia BA, Lowe SW, Asangani IA, Stanger BZ. Abstract A59: CRISPR screen identifies global regulation of H3K36me2 as an epigenomic mechanism underlying epithelial plasticity in pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A59  0.433
2019 Li J, Byrne KT, Markosyan N, Yamazoe T, Yan F, Chen Z, Sun YH, Lin J, Sela Y, Norgard RJ, Yuan S, Merrell AJ, Tobias JW, Vonderheide RH, Stanger BZ. Abstract A28: Investigation of tumor-cell-intrinsic factors regulating immune infiltration and response to immunotherapy in pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A28  0.44
2019 Carrer A, Trefely S, Zhao S, Campbell S, Sela Y, Sidoli S, Garcia BA, Snyder NW, Stanger BZ, Wellen KE. Abstract A03: All the roads bring to Rome: How acetyl-CoA metabolism supports multistep pancreatic carcinogenesis Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A03  0.44
2018 Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin JH, Sun YH, Rech AJ, Balli D, Hay CA, Sela Y, Merrell AJ, Liudahl SM, ... ... Stanger BZ, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity. PMID 29958801 DOI: 10.1016/J.Immuni.2018.06.006  0.421
2018 Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, Yamazoe T, Black T, Sahmoud A, Furth EE, Bar-Sagi D, Stanger BZ. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Developmental Cell. 45: 681-695.e4. PMID 29920274 DOI: 10.1016/J.Devcel.2018.05.027  0.779
2018 Bhagwat N, Dulmage K, Pletcher CH, Wang L, DeMuth W, Sen M, Balli D, Yee SS, Sa S, Tong F, Yu L, Moore JS, Stanger BZ, Dixon EP, Carpenter EL. An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters. Scientific Reports. 8: 5035. PMID 29568081 DOI: 10.1038/S41598-018-23217-5  0.409
2018 Rech AJ, Balli D, Mantero A, Ishwaran H, Nathanson KL, Stanger BZ, Vonderheide RH. Tumor immunity and survival as a function of alternative neopeptides in human cancer. Cancer Immunology Research. PMID 29339376 DOI: 10.1158/2326-6066.Cir-17-0559  0.349
2018 Natale CA, Li J, Zhang J, Dahal A, Dentchev T, Stanger BZ, Ridky TW. Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade. Elife. 7. PMID 29336307 DOI: 10.7554/Elife.31770  0.399
2018 Byrne KT, Li J, Vonderheide RH, Stanger BZ. Abstract 1011: Tumor cell intrinsic factors dictate T cell infiltration and therapeutic response in pancreatic ductal adenocarcinoma Tumor Biology. DOI: 10.1158/1538-7445.Am2018-1011  0.419
2018 Natale CA, Li J, Zhang J, Dahal A, Stanger B, Ridky T. Abstract B053: GPER signaling inhibits melanoma and improves response to PD-1 blockade Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B053  0.349
2017 Ko J, Bhagwat N, Yee SS, Ortiz N, Sahmoud A, Black T, Aiello NM, McKenzie L, O'Hara M, Redlinger C, Romeo J, Carpenter EL, Stanger BZ, Issadore D. Combining Machine Learning and Nanofluidic Technology to Diagnose Pancreatic Cancer Using Exosomes. Acs Nano. PMID 29019651 DOI: 10.1021/Acsnano.7B05503  0.327
2017 Ko J, Bhagwat N, Yee SS, Black T, Redlinger C, Romeo J, O'Hara M, Raj A, Carpenter EL, Stanger BZ, Issadore D. A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysis. Lab On a Chip. PMID 28809985 DOI: 10.1039/C7Lc00703E  0.363
2017 Aiello NM, Brabletz T, Kang Y, Nieto MA, Weinberg RA, Stanger BZ. Upholding a role for EMT in pancreatic cancer metastasis. Nature. 547: E7-E8. PMID 28682339 DOI: 10.1038/Nature22963  0.367
2017 Bhagwat N, Pletcher CH, Wang L, DeMuth W, Dulmage K, Balli D, Yee SS, Yu L, Moore JS, Stanger BZ, Dixon EP, Carpenter EL. Abstract 3801: A novel sensitive flow-cytometry based platform for isolation and molecular characterization of circulating tumor single cells and clusters Cancer Research. 77: 3801-3801. DOI: 10.1158/1538-7445.Am2017-3801  0.414
2016 Balli D, Rech AJ, Stanger BZ, Vonderheide RH. Immune cytolytic activity stratifies molecular subsets of human pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28007776 DOI: 10.1158/1078-0432.Ccr-16-2128  0.314
2016 Evans RA, Diamond MS, Rech AJ, Chao T, Richardson MW, Lin JH, Bajor DL, Byrne KT, Stanger BZ, Riley JL, Markosyan N, Winograd R, Vonderheide RH. Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. Jci Insight. 1. PMID 27642636 DOI: 10.1172/Jci.Insight.88328  0.38
2016 Aiello NM, Bajor DL, Norgard RJ, Sahmoud A, Bhagwat N, Pham MN, Cornish TC, Iacobuzio-Donahue CA, Vonderheide RH, Stanger BZ. Metastatic progression is associated with dynamic changes in the local microenvironment. Nature Communications. 7: 12819. PMID 27628423 DOI: 10.1038/Ncomms12819  0.369
2016 Yi J, Lu L, Yanger K, Wang W, Hwa Sohn B, Stanger BZ, Zhang M, Martin JF, Ajani JA, Chen J, Lee JS, Song S, Johnson RL. LATS1 and LATS2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Hepatology (Baltimore, Md.). PMID 27531557 DOI: 10.1002/Hep.28768  0.43
2016 Merrell AJ, Stanger BZ. Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style. Nature Reviews. Molecular Cell Biology. PMID 26979497 DOI: 10.1038/Nrm.2016.24  0.379
2016 Ariyachet C, Tovaglieri A, Xiang G, Lu J, Shah MS, Richmond CA, Verbeke C, Melton DA, Stanger BZ, Mooney D, Shivdasani RA, Mahony S, Xia Q, Breault DT, Zhou Q. Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation. Cell Stem Cell. PMID 26908146 DOI: 10.1016/J.Stem.2016.01.003  0.366
2016 Aiello NM, Stanger BZ. Echoes of the embryo: using the developmental biology toolkit to study cancer. Disease Models & Mechanisms. 9: 105-14. PMID 26839398 DOI: 10.1242/Dmm.023184  0.394
2016 Aiello NM, Rhim AD, Stanger BZ. Orthotopic Injection of Pancreatic Cancer Cells. Cold Spring Harbor Protocols. 2016: pdb.prot078360. PMID 26729902 DOI: 10.1101/Pdb.Prot078360  0.398
2016 Aiello NM, Rhim AD, Stanger BZ. Isolating Epithelial and Epithelial-to-Mesenchymal Transition Populations from Primary Tumors by Fluorescence-Activated Cell Sorting. Cold Spring Harbor Protocols. 2016: pdb.prot078352. PMID 26729901 DOI: 10.1101/Pdb.Prot078352  0.436
2016 Balli D, Aiello N, Norgard R, Li J, Sahmoud A, Stanger B. Abstract B10: Transcriptome analysis of mouse PDA subtypes Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-B10  0.445
2016 Balli D, Rech AJ, Stanger BZ, Vonderheide RH. Abstract IA23: Immune landscape of human pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-Ia23  0.361
2016 Stanger BZ. Abstract IA18: Probing tumor heterogeneity with mouse models Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-Ia18  0.329
2016 Carrer A, Lee JV, Shah S, Aiello NM, Snyder NW, Worth AJ, Blair IA, Stanger BZ, Wellen KE. Abstract PR03: Exploring the link between Kras and histone acetylation Cancer Research. 76. DOI: 10.1158/1538-7445.Chromepi15-Pr03  0.377
2016 McDonald PC, Chafe SC, Vallejo M, Schaeffer D, Yapp D, Supuran CT, Stanger B, Parmar M, Renouf D, Dedhar S. Abstract 754: Targeting carbonic anhydrase IX in multiple pancreatic ductal adenocarcinoma models results in tumor growth inhibition and increased survival Cancer Research. 76: 754-754. DOI: 10.1158/1538-7445.Am2016-754  0.45
2016 Aiello NM, Balli D, Norgard R, Li J, Sahmoud A, Stanger BZ. Abstract 2676: Epithelial-mesenchymal transition does not require transcriptional repression of the epithelial programin vivo Cancer Research. 76: 2676-2676. DOI: 10.1158/1538-7445.Am2016-2676  0.467
2015 Ghanem LR, Kromer A, Silverman IM, Chatterji P, Traxler E, Penzo-Mendez A, Weiss MJ, Stanger BZ, Liebhaber SA. The Poly(C) Binding Protein Pcbp2 and Its Retrotransposed Derivative Pcbp1 Are Independently Essential to Mouse Development. Molecular and Cellular Biology. 36: 304-19. PMID 26527618 DOI: 10.1128/Mcb.00936-15  0.307
2015 Stanger BZ. Probing hepatocyte heterogeneity. Cell Research. 25: 1181-2. PMID 26403190 DOI: 10.1038/Cr.2015.117  0.415
2015 Maddipati R, Stanger BZ. Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. Cancer Discovery. 5: 1086-97. PMID 26209539 DOI: 10.1158/2159-8290.Cd-15-0120  0.772
2015 Penzo-Méndez AI, Chen YJ, Li J, Witze ES, Stanger BZ. Spontaneous Cell Competition in Immortalized Mammalian Cell Lines. Plos One. 10: e0132437. PMID 26200654 DOI: 10.1371/Journal.Pone.0132437  0.374
2015 Spaeth JM, Hunter CS, Bonatakis L, Guo M, French CA, Slack I, Hara M, Fisher SE, Ferrer J, Morrisey EE, Stanger BZ, Stein R. The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice. Diabetologia. PMID 26021489 DOI: 10.1007/S00125-015-3635-3  0.378
2015 Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, ... ... Stanger BZ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 17: 816-26. PMID 25985394 DOI: 10.1038/Ncb3169  0.405
2015 Qu D, Johnson J, Chandrakesan P, Weygant N, May R, Aiello N, Rhim A, Zhao L, Zheng W, Lightfoot S, Pant S, Irvan J, Postier R, Hocker J, Hanas JS, ... ... Stanger B, et al. Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. Plos One. 10: e0118933. PMID 25723399 DOI: 10.1371/Journal.Pone.0118933  0.471
2015 Winograd R, Byrne KT, Evans RA, Odorizzi PM, Meyer AR, Bajor DL, Clendenin C, Stanger BZ, Furth EE, Wherry EJ, Vonderheide RH. Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma. Cancer Immunology Research. 3: 399-411. PMID 25678581 DOI: 10.1158/2326-6066.Cir-14-0215  0.385
2015 Stanger BZ. Cellular homeostasis and repair in the mammalian liver. Annual Review of Physiology. 77: 179-200. PMID 25668020 DOI: 10.1146/Annurev-Physiol-021113-170255  0.346
2015 Shen Z, Stanger BZ. YAP regulates S-phase entry in endothelial cells. Plos One. 10: e0117522. PMID 25635998 DOI: 10.1371/Journal.Pone.0117522  0.562
2015 Penzo-Méndez AI, Chen Y, Li J, Witze ES, Stanger BZ. Differences in energy metabolism drive cell competition in mammalian cells. Plos One. DOI: 10.1371/Journal.Pone.0132437.G005  0.31
2015 Carrer A, Lee JV, Shah S, Snyder NW, Jackson E, Aiello NM, Garcia BA, Chodosh LA, Stanger BZ, Blair IA, Wellen KE. Abstract B40: Oncogenic Kras induces histone acetylation in pancreatic ductal adenocarcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B40  0.367
2015 Aiello NM, Bajor DL, Pham MN, Vonderheide RH, Stanger BZ. Abstract 5176: Chemotherapy alters the natural history of metastatic progression Cancer Research. 75: 5176-5176. DOI: 10.1158/1538-7445.Am2015-5176  0.406
2015 Maddipati R, Stanger BZ. Abstract 4135: A polyclonal origin for pancreatic cancer metastases Cancer Research. 75: 4135-4135. DOI: 10.1158/1538-7445.Am2015-4135  0.338
2015 Ko JA, Bhagwat N, Yee SS, Carpenter E, Stanger B, Issadore D. Abstract 386: Rapid in situ RNA analysis of circulating tumor cells using magnetic micropore-based sorting and Turbo FISH Cancer Research. 75: 386-386. DOI: 10.1158/1538-7445.Am2015-386  0.401
2015 Dedhia PH, Finkbeiner SR, Altheim CH, Chen Y, Stanger BZ, Wolforth JB, Teitelbaum DH, Spence JR. Generation of Functional Insulin-Producing Cells from Pluipotent Stem Cell-Derived Human Intestinal Tissue Journal of the American College of Surgeons. 221: S157. DOI: 10.1016/J.Jamcollsurg.2015.07.375  0.325
2014 Penzo-Méndez AI, Stanger BZ. Cell competition in vertebrate organ size regulation. Wiley Interdisciplinary Reviews. Developmental Biology. 3: 419-27. PMID 25176591 DOI: 10.1002/Wdev.148  0.417
2014 Yanger K, Knigin D, Zong Y, Maggs L, Gu G, Akiyama H, Pikarsky E, Stanger BZ. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell. 15: 340-9. PMID 25130492 DOI: 10.1016/J.Stem.2014.06.003  0.598
2014 Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, Worth AJ, Yuan ZF, Lim HW, Liu S, Jackson E, Aiello NM, Haas NB, Rebbeck TR, Judkins A, ... ... Stanger BZ, et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metabolism. 20: 306-19. PMID 24998913 DOI: 10.1016/J.Cmet.2014.06.004  0.349
2014 Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. Hippo pathway activity influences liver cell fate. Cell. 157: 1324-38. PMID 24906150 DOI: 10.1016/J.Cell.2014.03.060  0.453
2014 Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP, Tattersall IW, Westphalen CB, Kitajewski J, Fernandez-Barrena MG, Fernandez-Zapico ME, Iacobuzio-Donahue C, ... ... Stanger BZ, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 25: 735-47. PMID 24856585 DOI: 10.1016/J.Ccr.2014.04.021  0.404
2014 Wang T, Yanger K, Stanger BZ, Cassio D, Bi E. Cytokinesis defines a spatial landmark for hepatocyte polarization and apical lumen formation. Journal of Cell Science. 127: 2483-92. PMID 24706948 DOI: 10.1242/Jcs.139923  0.347
2014 Yanger K, Stanger BZ. Liver cell reprogramming: parallels with iPSC biology. Cell Cycle (Georgetown, Tex.). 13: 1211-2. PMID 24621496 DOI: 10.4161/Cc.28381  0.449
2014 Chen YJ, Finkbeiner SR, Weinblatt D, Emmett MJ, Tameire F, Yousefi M, Yang C, Maehr R, Zhou Q, Shemer R, Dor Y, Li C, Spence JR, Stanger BZ. De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts. Cell Reports. 6: 1046-58. PMID 24613355 DOI: 10.1016/J.Celrep.2014.02.013  0.371
2014 Gao T, McKenna B, Li C, Reichert M, Nguyen J, Singh T, Yang C, Pannikar A, Doliba N, Zhang T, Stoffers DA, Edlund H, Matschinsky F, Stein R, Stanger BZ. Pdx1 maintains β cell identity and function by repressing an α cell program. Cell Metabolism. 19: 259-71. PMID 24506867 DOI: 10.1016/J.Cmet.2013.12.002  0.368
2014 Rhim AD, Thege FI, Santana SM, Lannin TB, Saha TN, Tsai S, Maggs LR, Kochman ML, Ginsberg GG, Lieb JG, Chandrasekhara V, Drebin JA, Ahmad N, Yang YX, Kirby BJ, ... Stanger BZ, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology. 146: 647-51. PMID 24333829 DOI: 10.1053/J.Gastro.2013.12.007  0.423
2014 Takano S, Reichert M, Heeg S, Bakir B, Das KK, Rhim AD, Yoshitomi H, Stanger B, Rustgi AK. Tu1665 Prrx1a and Prrx1b Differentially Regulate Invasion and Metastasis in Pancreatic Cancer Gastroenterology. 146: S-813. DOI: 10.1016/S0016-5085(14)62941-3  0.393
2013 Zheng R, Rebolledo-Jaramillo B, Zong Y, Wang L, Russo P, Hancock W, Stanger BZ, Hardison RC, Blobel GA. Function of GATA factors in the adult mouse liver. Plos One. 8: e83723. PMID 24367609 DOI: 10.1371/Journal.Pone.0083723  0.568
2013 Madison BB, Liu Q, Zhong X, Hahn CM, Lin N, Emmett MJ, Stanger BZ, Lee JS, Rustgi AK. LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7. Genes & Development. 27: 2233-45. PMID 24142874 DOI: 10.1101/Gad.224659.113  0.356
2013 Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Research. 73: 6359-74. PMID 24097820 DOI: 10.1158/0008-5472.Can-13-1558-T  0.374
2013 Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q, Shimono A, Sudol M, Holmgren L, Stanger BZ, Kissil JL. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Science Signaling. 6: ra77. PMID 24003254 DOI: 10.1126/Scisignal.2004060  0.556
2013 Stanger BZ, Kahn ML. Platelets and tumor cells: a new form of border control. Cancer Cell. 24: 9-11. PMID 23845439 DOI: 10.1016/J.Ccr.2013.06.009  0.411
2013 Kim J, Hoffman JP, Alpaugh RK, Rhim AD, Rhimm AD, Reichert M, Stanger BZ, Furth EE, Sepulveda AR, Yuan CX, Won KJ, Donahue G, Sands J, Gumbs AA, Zaret KS. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Reports. 3: 2088-99. PMID 23791528 DOI: 10.1016/J.Celrep.2013.05.036  0.416
2013 Stanger BZ, Hebrok M. Control of cell identity in pancreas development and regeneration. Gastroenterology. 144: 1170-9. PMID 23622126 DOI: 10.1053/J.Gastro.2013.01.074  0.382
2013 Yanger K, Zong Y, Maggs LR, Shapira SN, Maddipati R, Aiello NM, Thung SN, Wells RG, Greenbaum LE, Stanger BZ. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes & Development. 27: 719-24. PMID 23520387 DOI: 10.1101/Gad.207803.112  0.619
2013 Gao T, Zhou D, Yang C, Singh T, Penzo-Méndez A, Maddipati R, Tzatsos A, Bardeesy N, Avruch J, Stanger BZ. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology. 144: 1543-53, 1553.e1. PMID 23454691 DOI: 10.1053/J.Gastro.2013.02.037  0.765
2013 Reichert M, Takano S, von Burstin J, Kim SB, Lee JS, Ihida-Stansbury K, Hahn C, Heeg S, Schneider G, Rhim AD, Stanger BZ, Rustgi AK. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes & Development. 27: 288-300. PMID 23355395 DOI: 10.1101/Gad.204453.112  0.441
2013 Aiello NM, Bajor DL, Vonderheide RH, Stanger BZ. Abstract PR14: Lineage labeling elucidates the natural history of metastatic colonization Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Pr14  0.446
2013 Madison B, Liu Q, Zhong X, Hahn CM, Lin N, Emmet M, Stanger BZ, Rustgi AK. Abstract PR04: LIN28B promotes growth and tumorigenesis of the intestinal epithelium primarily via Let-7 repression Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Pr04  0.43
2013 Takano S, Reichert M, Heeg S, Bakir B, Rhim AD, Stanger B, Rustgi AK. 339 The Prrx1 Homeobox Transcription Factor Regulates Invasion and EMT in Pancreatic Cancer Gastroenterology. 144: S-71. DOI: 10.1016/S0016-5085(13)60263-2  0.375
2012 Zong Y, Stanger BZ. Molecular mechanisms of liver and bile duct development. Wiley Interdisciplinary Reviews. Developmental Biology. 1: 643-55. PMID 23799566 DOI: 10.1002/Wdev.47  0.589
2012 Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, Toffanin S, Rodriguez-Carunchio L, Solé M, Thung S, Stanger BZ, Llovet JM. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology. 143: 1660-1669.e7. PMID 22974708 DOI: 10.1053/J.Gastro.2012.09.002  0.627
2012 Stanger BZ. Quit your YAPing: a new target for cancer therapy. Genes & Development. 26: 1263-7. PMID 22713867 DOI: 10.1101/Gad.196501.112  0.385
2012 Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 21: 822-35. PMID 22698406 DOI: 10.1016/J.Ccr.2012.04.025  0.439
2012 Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZ. EMT and dissemination precede pancreatic tumor formation. Cell. 148: 349-61. PMID 22265420 DOI: 10.1016/J.Cell.2011.11.025  0.475
2012 Rhim AD, Aiello NM, Mirek ET, Stanger BZ. Abstract IA5: EMT and dissemination precede pancreatic tumor formation. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-Ia5  0.455
2012 Kim J, Zaret KS, Hoffman JP, Reichert M, Rhim AD, Stanger BZ, Gumbs A. Abstract B98: Induced pluripotent stem cells from pancreatic ductal adenocarcinoma can recapitulate early developmental stages of cancer. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B98  0.438
2012 Reichert M, Rustgi AK, Takano S, Burstin JAv, Heeg S, Botta GP, Lee J, Schneider G, Rhim AD, Stanger BZ. Abstract A71: The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A71  0.448
2012 Stanger BZ. Abstract SY04-02: Reaching escape velocity: Using lineage tracing to study EMT and dissemination in pancreatic cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Sy04-02  0.431
2012 Rhim AD, Reichert M, Rustgi AK, Stanger B. Mo1189 Inflammation is Sufficient and Required to Elicit EMT, Invasion and Dissemination of Pancreas Cells in a Genetically Engineered Mouse Model of Pancreatic Intraepithelial Neoplasia (PanIN) Gastroenterology. 142: S-617. DOI: 10.1016/S0016-5085(12)62369-5  0.375
2011 Magenheim J, Klein AM, Stanger BZ, Ashery-Padan R, Sosa-Pineda B, Gu G, Dor Y. Ngn3(+) endocrine progenitor cells control the fate and morphogenesis of pancreatic ductal epithelium. Developmental Biology. 359: 26-36. PMID 21888903 DOI: 10.1016/J.Ydbio.2011.08.006  0.456
2011 Chu AS, Diaz R, Hui JJ, Yanger K, Zong Y, Alpini G, Stanger BZ, Wells RG. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology (Baltimore, Md.). 53: 1685-95. PMID 21520179 DOI: 10.1002/Hep.24206  0.602
2011 Yanger K, Stanger BZ. Facultative stem cells in liver and pancreas: fact and fancy. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 240: 521-9. PMID 21312313 DOI: 10.1002/Dvdy.22561  0.384
2011 Zong Y, Stanger BZ. Molecular mechanisms of bile duct development. The International Journal of Biochemistry & Cell Biology. 43: 257-64. PMID 20601079 DOI: 10.1016/J.Biocel.2010.06.020  0.621
2011 Alsinet C, Yanger K, Villanueva A, Hoshida Y, Zhong Y, Toffanin S, Cabellos L, Thung S, Stanger BZ, Llovet JM. Abstract 2410: Characterization of Notch as an oncogenic driver in liver Cancer Research. 71: 2410-2410. DOI: 10.1158/1538-7445.Am2011-2410  0.384
2011 Rhim AD, Stanger B. Epithelial-to-Mesenchymal Transition and Hematogenous Dissemination Precedes Histologic Diagnosis of Cancer in a Genetic Mouse Model of Pancreatic Ductal Adenocarcinoma Gastroenterology. 140: S-162. DOI: 10.1016/S0016-5085(11)60657-4  0.357
2010 Rhim AD, Stanger BZ. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways. Progress in Molecular Biology and Translational Science. 97: 41-78. PMID 21074729 DOI: 10.1016/B978-0-12-385233-5.00002-7  0.438
2010 Pan W, Jin Y, Stanger B, Kiernan AE. Notch signaling is required for the generation of hair cells and supporting cells in the mammalian inner ear. Proceedings of the National Academy of Sciences of the United States of America. 107: 15798-803. PMID 20733081 DOI: 10.1073/Pnas.1003089107  0.402
2010 Hanlon L, Avila JL, Demarest RM, Troutman S, Allen M, Ratti F, Rustgi AK, Stanger BZ, Radtke F, Adsay V, Long F, Capobianco AJ, Kissil JL. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Research. 70: 4280-6. PMID 20484026 DOI: 10.1158/0008-5472.Can-09-4645  0.355
2010 Stanger BZ. Abstract CN10-02: Notch signaling in the progression of pancreatic cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-Cn10-02  0.425
2010 Liu J, Kong J, Stanger B, Lynch JP. S1683 Cre-Regulated CDx2 Expression in Colon Cancer Cells Gastroenterology. 138: S-253. DOI: 10.1016/S0016-5085(10)61153-5  0.38
2010 Rhim AD, Rustgi AK, Stanger B. 406 Paracrine Hedgehog Activation in Myofibroblasts Leads to Reciprocal Dedifferentiation and Proliferation of Pancreatic Intraepithelial Neoplasia (PanIN) Epithelial Cells: Insight Into the Role of Stromal-Epithelial Interactions in Cancer Progression Gastroenterology. 138: S-60. DOI: 10.1016/S0016-5085(10)60274-0  0.442
2009 Antoniou A, Raynaud P, Cordi S, Zong Y, Tronche F, Stanger BZ, Jacquemin P, Pierreux CE, Clotman F, Lemaigre FP. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology. 136: 2325-33. PMID 19403103 DOI: 10.1053/J.Gastro.2009.02.051  0.588
2009 Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Stanger BZ. Notch signaling controls liver development by regulating biliary differentiation. Development (Cambridge, England). 136: 1727-39. PMID 19369401 DOI: 10.1242/Dev.029140  0.626
2009 Guseh JS, Bores SA, Stanger BZ, Zhou Q, Anderson WJ, Melton DA, Rajagopal J. Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. Development (Cambridge, England). 136: 1751-9. PMID 19369400 DOI: 10.1242/Dev.029249  0.402
2009 Plentz R, Park JS, Rhim AD, Abravanel D, Hezel AF, Sharma SV, Gurumurthy S, Deshpande V, Kenific C, Settleman J, Majumder PK, Stanger BZ, Bardeesy N. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology. 136: 1741-9.e6. PMID 19208345 DOI: 10.1053/J.Gastro.2009.01.008  0.436
2009 Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Stanger BZ. The role of Notch signaling in the bile duct development Developmental Biology. 331: 513. DOI: 10.1016/J.Ydbio.2009.05.472  0.582
2008 Zong Y, Panikkar A, Stanger BZ. Notch signaling acts at multiple stages to regulate bile duct morphogenesis Developmental Biology. 319: 505-506. DOI: 10.1016/J.Ydbio.2008.05.137  0.577
2007 Stanger BZ, Tanaka AJ, Melton DA. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature. 445: 886-91. PMID 17259975 DOI: 10.1038/Nature05537  0.359
2006 Xu Y, Wang S, Zhang J, Zhao A, Stanger BZ, Gu G. The fringe molecules induce endocrine differentiation in embryonic endoderm by activating cMyt1/cMyt3. Developmental Biology. 297: 340-9. PMID 16920096 DOI: 10.1016/J.Ydbio.2006.04.456  0.429
2006 Stanger BZ, Dor Y. Dissecting the cellular origins of pancreatic cancer. Cell Cycle (Georgetown, Tex.). 5: 43-6. PMID 16322695 DOI: 10.4161/Cc.5.1.2291  0.473
2005 Stanger BZ, Stiles B, Lauwers GY, Bardeesy N, Mendoza M, Wang Y, Greenwood A, Cheng KH, McLaughlin M, Brown D, Depinho RA, Wu H, Melton DA, Dor Y. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell. 8: 185-95. PMID 16169464 DOI: 10.1016/J.Ccr.2005.07.015  0.436
2005 Stanger BZ, Datar R, Murtaugh LC, Melton DA. Direct regulation of intestinal fate by Notch. Proceedings of the National Academy of Sciences of the United States of America. 102: 12443-8. PMID 16107537 DOI: 10.1073/Pnas.0505690102  0.386
2003 Murtaugh LC, Stanger BZ, Kwan KM, Melton DA. Notch signaling controls multiple steps of pancreatic differentiation. Proceedings of the National Academy of Sciences of the United States of America. 100: 14920-5. PMID 14657333 DOI: 10.1073/Pnas.2436557100  0.439
1998 Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 8: 297-303. PMID 9529147 DOI: 10.1016/S1074-7613(00)80535-X  0.337
1996 Stanger BZ. Looking beneath the surface: The cell death pathway of Fas/APO-1 (CD95) Molecular Medicine. 2: 7-20. PMID 8900530 DOI: 10.1007/Bf03402198  0.355
1996 Grimm S, Stanger BZ, Leder P. RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proceedings of the National Academy of Sciences of the United States of America. 93: 10923-7. PMID 8855284 DOI: 10.1073/Pnas.93.20.10923  0.306
1995 Rothstein TL, Wang JKM, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST, Marshak-Rothstein A. Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells Nature. 374: 163-165. PMID 7533263 DOI: 10.1038/374163A0  0.308
1995 Ju ST, Panka DJ, Cui H, Ettinger R, Ei-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation Nature. 373: 444-448. PMID 7530337 DOI: 10.1038/373444A0  0.321
1989 Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 86: 4614-8. PMID 2734311 DOI: 10.1073/Pnas.86.12.4614  0.341
Show low-probability matches.